Investigation of maternal serum hepassocin concentrations in pregnant women with gestational diabetes mellitus: a prospective case-control study.

Aysegul Cakmakİbrahim KaleMurat Muhcu

Published in: Zeitschrift fur Geburtshilfe und Neonatologie (2023)

Serum hepassocin concentration evaluated between 24 and 28 weeks of gestation was found to be higher in pregnant women with GDM than in the non-GDM group. The highest serum hepassocin concentration was found in the GDM group using insulin for blood glucose regulation. Hepassocin seems to be a promising molecule that can be used in GDM screening in pregnant women who do not want to have an OGTT in the future.

Keyphrases

pregnant women
blood glucose
pregnancy outcomes
type diabetes
glycemic control
preterm infants
gestational age
current status
birth weight
adipose tissue
preterm birth